Authors:
Wang, YG
Chackalamannil, S
Chang, W
Greenlee, W
Ruperto, V
Duffy, RA
McQuade, R
Citation: Yg. Wang et al., Design and synthesis of ether analogues as potent and selective M-2 muscarinic receptor antagonists, BIOORG MED, 11(7), 2001, pp. 891-894
Authors:
Boyle, CD
Chackalamannil, S
Clader, JW
Greenlee, WJ
Josien, HB
Kaminski, JJ
Kozlowski, JA
McCombie, SW
Nazareno, DV
Tagat, JR
Wang, YG
Zhou, GW
Billard, W
Binch, H
Crosby, G
Cohen-Williams, M
Coffin, VL
Cox, KA
Grotz, DE
Duffy, RA
Ruperto, V
Lachowicz, JE
Citation: Cd. Boyle et al., Metabolic stabilization of benzylidene ketal M-2 muscarinic receptor antagonists via halonaphthoic acid substitution, BIOORG MED, 11(17), 2001, pp. 2311-2314
Authors:
Boyle, CD
Chackalamannil, S
Chen, LY
Dugar, S
Pushpavanam, P
Billard, W
Binch, H
Crosby, G
Cohen-Williams, M
Coffin, VL
Duffy, RA
Ruperto, V
Lachowicz, JE
Citation: Cd. Boyle et al., Benzylidene ketal derivatives as M-2 muscarinic receptor antagonists, BIOORG MED, 10(24), 2000, pp. 2727-2730
Authors:
Wang, YG
Chackalamannil, S
Hu, ZY
Clader, JW
Greenlee, W
Billard, W
Binch, H
Crosby, G
Ruperto, V
Duffy, RA
McQuade, R
Lachowicz, JE
Citation: Yg. Wang et al., Design and synthesis of piperidinyl piperidine analogues as potent and selective M-2 muscarinic receptor antagonists, BIOORG MED, 10(20), 2000, pp. 2247-2250
Citation: Yg. Wang et al., Stereochemistry of the oxidation of imines derived from substituted cyclohexanones: Axial vs equatorial attack and evidence for delivery by an adjacent hydroxyl group, J ORG CHEM, 65(17), 2000, pp. 5120-5126
Authors:
Doller, D
Chackalamannil, S
Czarniecki, M
McQuade, R
Ruperto, V
Citation: D. Doller et al., Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists, BIOORG MED, 9(6), 1999, pp. 901-906